| PHIN2004-1 | | Active substances | | Holder |
| | - | Substances emerging from pharmacochemical research, part a | | |
| | - | Substances emerging from pharmacochemical research, part b | | |
| | - | Substances emerging from biotechnology, | | |
| | - | Substances of natural origin, part a | | |
| | - | Substances of natural origin, part b | | |
| | - | Radiopharmaceuticals products, | | |
| PHIN2029-2 | | Regulation and the medical-social environment | | Holder |
| | - | Economic aspects of drug development | | |
| | - | Legislation and procedures applied to pharmaceutical industry, part a : legislation | | |
| | - | Legislation and procedures applied to pharmaceutical industry, part b : patents and protection | | |
| | - | Macroeconomic environment and pharmaco-economics | | |
| | - | CTD File (Common Technical Document) | | |
| | - | Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files | | |
| | - | Regulations of preclinical and clinical studies, part b : clinical studies | | |
| | - | Regulations of preclinical and clinical studies, part c : pediatric studies | | |
| | - | Specific regulatory issues, part a : medicine and herbal dietary supplement | | |
| | - | Specific regulatory issues, part b : Preformulation and galenical development documentation | | |